QI
PTCT icon

QS Investors’s PTC Therapeutics PTCT Stock Holding History

QS Investors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,650
Closed -$452K – 1244
2020
Q3 		$452K Sell
9,650
-44,500
-82% -$2.19M 0.01% 742
2020
Q2 		$2.75M Sell
54,150
-450
-0.8% -$22.1K 0.04% 369
2020
Q1 		$2.44M Sell
54,600
-3,850
-7% -$194K 0.04% 351
2019
Q4 		$2.83M Sell
58,450
-29,800
-34% -$1.27M 0.03% 467
2019
Q3 		$2.98M Sell
88,250
-2,200
-2% -$95.8K 0.03% 423
2019
Q2 		$4.07M Buy
90,450
+3,174
+4% +$125K 0.04% 335
2019
Q1 		$3.29M Sell
87,276
-52,474
-38% -$1.76M 0.04% 399
2018
Q4 		$4.8M Hold
139,750
– – 0.06% 227
2018
Q3 		$6.57M Sell
139,750
-70,257
-33% -$2.91M 0.06% 203
2018
Q2 		$7.08M Hold
210,007
– – 0.07% 192
2018
Q1 		$5.68M Sell
210,007
-10,811
-5% -$274K 0.06% 220
2017
Q4 		$3.68M Sell
220,818
-8,520
-4% -$144K 0.03% 401
2017
Q3 		$4.59M Sell
229,338
-5,497
-2% -$108K 0.04% 339
2017
Q2 		$4.3M Hold
234,835
– – 0.04% 354
2017
Q1 		$2.31M Buy
234,835
+9,468
+4% +$115K 0.02% 554
2016
Q4 		$2.46M Hold
225,367
– – 0.02% 560
2016
Q3 		$3.16M Buy
225,367
+6,161
+3% +$50.1K 0.02% 523
2016
Q2 		$1.54M Buy
+219,206
New +$1.61M 0.01% 691

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

QS Investors's PTCT Position: Q4 2020 in Review

QS Investors sold out of PTC Therapeutics (PTCT) in Q4 2020, closing a stake of 9,650 shares — an estimated $452K sold.

QS Investors first reported a position in PTCT in Q2 2016 and held it in 18 quarters. The position peaked at $7.08M in Q2 2018. 214 funds tracked by Wall St. Rank hold PTCT as of Q4 2020.

  • QS Investors reported no remaining PTC Therapeutics position as of Q4 2020 after selling out during the quarter.
  • QS Investors sold 9,650 PTC Therapeutics shares in Q4 2020, an estimated $452K.
  • QS Investors first reported a position in PTC Therapeutics in Q2 2016 and held it in 18 quarters.
  • QS Investors's PTC Therapeutics position peaked at $7.08M in Q2 2018.
  • 214 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.